India Glycols Limited

NSE: INDIAGLYCO

36

total announcements

INDIAGLYCO.NS · 15 min delayed

NSETrading Windowtrading_window5 Aug 2026

India Glycols Limited

Trading Window

India Glycols Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in the securities of the Company has been closed from Wednesday, 1st July, 2026 and will remain closed till Friday, 14th August, 2026.

Read more →📎 1 attachment
NSEUpdatesMgmt Change4 Aug 2026

India Glycols Limited

Updates

India Glycols Limited has informed the Exchange regarding the appointment of Shri Manoj Kumar Rai as an Additional Director (in the category of Executive Director) & Key Managerial Personnel, designated as Executive Director & Chief Operating Officer, with effect from 4th August, 2026, for a term of 5 (five) consecutive years.

Read more →📎 1 attachment
NSEUpdatesMgmt Change31 Jul 2026

India Glycols Limited

Updates

India Glycols Limited has informed the Exchange regarding a material update in connection with Ennature Bio Pharma Limited, a wholly owned subsidiary, regarding the appointment of Shri Akshay Bansal as Additional Director (Executive Director) & Key Managerial Personnel.

Read more →📎 1 attachment
NSECessationMgmt Change31 Jul 2026

India Glycols Limited

Cessation

India Glycols Limited has informed the Exchange regarding the cessation of Mr. Akshay Bansal as Other of the company w.e.f. July 30, 2026, and his appointment as Additional Director (Executive Director) & Key Managerial Personnel at Ennature Bio Pharma Limited, a wholly owned subsidiary of the company.

Read more →📎 1 attachment
NSECopy of Newspaper Publication25 Jul 2026

India Glycols Limited

Copy of Newspaper Publication

India Glycols Limited has informed the Exchange about Copy of Newspaper Publication regarding Notice of 42nd Annual General Meeting, Annual Report for FY 2025-26 and E-voting information.

Read more →📎 1 attachment
NSEUpdatesResults25 Jul 2026

India Glycols Limited

Updates

India Glycols Limited has informed the Exchange regarding 'Intimation of web-link of the Annual Report for FY 2025-26'. The company has sent a letter containing web-link, including the exact path, to access the Annual Report for FY 2025-26, to all those Shareholders whose e-mail addresses are not registered with the Company/ Registrar & Share Transfer Agent or Depositories Participants.

Read more →📎 1 attachment
NSEShareholders meetingResults24 Jul 2026

India Glycols Limited

Shareholders meeting

India Glycols Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on August 19, 2026.

Read more →📎 1 attachment
NSECopy of Newspaper Publication23 Jul 2026

India Glycols Limited

Copy of Newspaper Publication

India Glycols Limited has informed the Exchange about the submission of newspaper clippings of the Notice of 42nd Annual General Meeting to be held on August 19, 2026, through Video Conferencing (VC)/Other Audio Visual Means (OAVM).

Read more →📎 1 attachment
NSEUpdates22 Jul 2026

India Glycols Limited

Updates

India Glycols Limited has informed the Exchange regarding 'Intimation of 42nd Annual General Meeting'. The 42nd AGM of the Company is scheduled to be held on Wednesday, 19th August, 2026 at 11:00 A.M. (IST) through Video Conferencing/Other Audio Visual Means (VC/OAVM). The Notice of the 42nd AGM of the Company and the Annual Report for the Financial Year 2025-26 will be sent by e-mail to all those Shareholders whose e-mail addresses are registered with the Company/RTA/Depository Participants and will also be available on the Company's website at www.indiaglycols.com in due course.

Read more →📎 1 attachment
NSEUpdatesM&A20 Jul 2026

India Glycols Limited

Updates

India Glycols Limited has informed the Exchange regarding 'Update on Scheme of Arrangement'. The Hon'ble National Company Law Tribunal, Allahabad Bench at Prayagraj has sanctioned the Scheme of Arrangement amongst India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited. The Bio Pharma and the Spirits and Biofuel Undertakings will be transferred to and vested in Ennature Bio Pharma Limited and IGL Spirits Limited, respectively. The Appointed Date of the Scheme is 1st April, 2026.

Read more →📎 1 attachment
NSEUpdatesRegulatory17 Jul 2026

India Glycols Limited

Updates

India Glycols Limited has informed the Exchange regarding 'Update on hearing before NCLT, Allahabad Bench at Prayagraj'. The Hon'ble National Company Law Tribunal, Allahabad Bench at Prayagraj has pronounced its Order, sanctioning the Scheme of Arrangement amongst India Glycols Limited, Ennature Bio Pharma Limited, and IGL Spirits Limited.

Read more →📎 1 attachment
NSEGeneral UpdatesM&A3 Jul 2026

India Glycols Limited

General Updates

India Glycols Limited has informed the Exchange about General Updates on the Scheme of Arrangement amongst India Glycols Limited, Ennature Bio pharma Limited, and IGL Spirits Limited. The Hon'ble National Company Law Tribunal, Allahabad Bench at Prayagraj has reserved the matter for final pronouncement.

Read more →📎 1 attachment
NSEUpdatesMgmt Change2 Jul 2026

India Glycols Limited

Updates

India Glycols Limited has informed the Exchange regarding the appointment of Chief Operating Officer by its wholly owned subsidiary IGL Spirits Limited.

Read more →📎 1 attachment
NSETrading Window26 Jun 2026

India Glycols Limited

Trading Window

India Glycols Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015.

Read more →📎 1 attachment
NSECopy of Newspaper Publication19 Jun 2026

India Glycols Limited

Copy of Newspaper Publication

India Glycols Limited has announced the publication of a newspaper advertisement dated June 19, 2026. This advertisement informs shareholders about a special window opened for the transfer and dematerialisation of the company's physical shares. It also refers to the "Second 100 Days' Campaign – Saksham Niveshak," as per SEBI regulations. This initiative facilitates the conversion of physical share certificates into electronic form. For investors, this offers a crucial opportunity to streamline their holdings, enhancing ease of trading and compliance.

Read more →📎 1 attachment
← PreviousPage 2 of 2